115 related articles for article (PubMed ID: 3040340)
21. The effects of BW755C and other anti-inflammatory drugs on eicosanoid concentrations and leukocyte accumulation in experimentally-induced acute inflammation.
Salmon JA; Simmons PM; Moncada S
J Pharm Pharmacol; 1983 Dec; 35(12):808-13. PubMed ID: 6141244
[TBL] [Abstract][Full Text] [Related]
22. Multicentre double-blind study of the efficacy, safety and tolerance of pirazolac compared with sulindac in patients with rheumatoid arthritis.
Numo R
Drugs Exp Clin Res; 1990; 16(1):17-27. PubMed ID: 2198156
[TBL] [Abstract][Full Text] [Related]
23. Measurement of sulfidopeptide leukotrienes and their metabolism in human synovial fluid of patients with rheumatoid arthritis.
Koshihara Y; Isono T; Oda H; Karube S; Hayashi Y
Prostaglandins Leukot Essent Fatty Acids; 1988 Jun; 32(3):113-9. PubMed ID: 2842805
[TBL] [Abstract][Full Text] [Related]
24. [Levels of different metabolites of arachidonic acid in synovial fluid of patients with arthrosis or rheumatoid arthritis].
Grignani G; Zucchella M; Belai Beyene N; Brocchieri A; Saporiti A; Chériè Ligniére EL
Minerva Med; 1996 Mar; 87(3):75-9. PubMed ID: 8668291
[TBL] [Abstract][Full Text] [Related]
25. Release of leukotrienes C4 and B4 and prostaglandin E2 from human monocytes stimulated with aggregated IgG, IgA, and IgE.
Ferreri NR; Howland WC; Spiegelberg HL
J Immunol; 1986 Jun; 136(11):4188-93. PubMed ID: 3009617
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of 5-lipoxygenase product formation and polymorphonuclear cell degranulation by tenidap sodium in patients with rheumatoid arthritis.
Blackburn WD; Heck LW; Loose LD; Eskra JD; Carty TJ
Arthritis Rheum; 1991 Feb; 34(2):204-10. PubMed ID: 1847289
[TBL] [Abstract][Full Text] [Related]
27. Eicosanoid production in rheumatoid synovitis.
Moilanen E; Alanko J; Nissilä M; Hämäläinen M; Isomäki H; Vapaatalo H
Agents Actions; 1989 Nov; 28(3-4):290-7. PubMed ID: 2556902
[TBL] [Abstract][Full Text] [Related]
28. [Prostaglandins E2 and F2 alpha concentrations in the synovial fluid in rheumatoid and traumatic knee joint diseases].
Egg D; Günther R; Herold M; Kerschbaumer F
Z Rheumatol; 1980; 39(5-6):170-5. PubMed ID: 7415586
[TBL] [Abstract][Full Text] [Related]
29. [Prostanoids in children with joint diseases].
Iakovleva AA; Sadykova UT; Markov KhM
Revmatologiia (Mosk); 1990; (3):3-7. PubMed ID: 1965930
[TBL] [Abstract][Full Text] [Related]
30. [Trans-synovial kinetics of tiaprofenic acid].
Kurowski M
Z Rheumatol; 1988; 47(3):173-6. PubMed ID: 3213265
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of eicosanoid release from synovial organ culture by incubation with tepoxalin and its acid metabolite.
Willburger RE; Wittenberg RH; Kleemeyer KS; Hoos R; Brunner-Ferber FL; Peskar BA
Prostaglandins; 1996 Oct; 52(4):327-38. PubMed ID: 8936587
[TBL] [Abstract][Full Text] [Related]
32. [Comparative elimination of pirprofen from the plasma and synovial fluid of the knee. 26 cases].
Schoeller JP; Schwarzberg C; Gerardin A; Colussi D; Sioufi A; Hirtz J
Presse Med; 1983 Sep; 12(33):2045-7. PubMed ID: 6226019
[TBL] [Abstract][Full Text] [Related]
33. Leukotriene B4, an inflammatory mediator in gout.
Rae SA; Davidson EM; Smith MJ
Lancet; 1982 Nov; 2(8308):1122-4. PubMed ID: 6128450
[TBL] [Abstract][Full Text] [Related]
34. The transsynovial distribution of oxaprozin.
Kurowski M; Thabe H
Agents Actions; 1989 Jun; 27(3-4):458-60. PubMed ID: 2801338
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of pirazolac--a new anti-inflammatory drug--in human volunteers. I. Absorption, disposition, biotransformation and excretion.
Täuber U; Weiss C; Krause W; Acksteiner B; Matthes H
Eur J Drug Metab Pharmacokinet; 1985; 10(1):41-53. PubMed ID: 4029220
[TBL] [Abstract][Full Text] [Related]
36. Leukotriene B4 metabolism in human leukocytes: fact or artefact?
McMillan RM; Foster SJ; Dieppe PA
Agents Actions; 1987 Aug; 21(3-4):355-7. PubMed ID: 2825483
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of lumiracoxib in plasma and synovial fluid.
Scott G; Rordorf C; Reynolds C; Kalbag J; Looby M; Milosavljev S; Weaver M; Huff JP; Ruff DA
Clin Pharmacokinet; 2004; 43(7):467-78. PubMed ID: 15139795
[TBL] [Abstract][Full Text] [Related]
38. Penetration of the active metabolite of nabumetone into synovial fluid and adherent tissue of patients undergoing knee joint surgery.
Miehlke RK; Schneider S; Sörgel F; Muth P; Henschke F; Giersch KH; Münzel P
Drugs; 1990; 40 Suppl 5():57-61. PubMed ID: 2081495
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the effects of different anti-inflammatory drugs on synovial fluid prostanoid concentrations in patients with rheumatoid arthritis.
Seppälä E; Nissilä M; Isomäki H; Nuotio P; Nykänen E; Laitinen O; Vapaatalo H
Clin Rheumatol; 1985 Sep; 4(3):315-20. PubMed ID: 3864577
[TBL] [Abstract][Full Text] [Related]
40. Levels of prostaglandins F2 alpha and E2 and thromboxane B2 in joint fluid in rheumatoid arthritis.
Trang LE; Granström E; Lövgren O
Scand J Rheumatol; 1977; 6(3):151-4. PubMed ID: 929121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
